ArticleChinese medical journal2019

Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer.

Chao Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.